WallStSmart
LITS

Lite Strategy, Inc.

NASDAQ: LITS · HEALTHCARE · BIOTECHNOLOGY

$1.25
-13.35% today

Updated 2026-06-05

Market cap
$25.47M
P/E ratio
P/S ratio
0.30x
EPS (TTM)
$-2.08
Dividend yield
52W range
$1 – $8
Volume
0.4M

Lite Strategy, Inc. (LITS) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20212022202320242025
Total assets$174.10M$177.84M$120.81M$41.38M$18.29M
Cash & equivalents$8.54M$15.74M$16.91M$3.71M$18.01M
Current assets$164.82M$167.13M$107.53M$40.77M$18.29M
Total liabilities$124.63M$125.43M$96.19M$8.36M$1.35M
Current liabilities$20.21M$24.44M$20.34M$8.36M$1.35M
Long-term debt
Shareholder equity$49.47M$52.41M$24.62M$33.02M$16.93M
Retained earnings$-319.70M$-374.16M$-406.00M$-388.22M$-404.16M
Accounts receivable$7.58M$10.04M$85000.00
Inventory
Goodwill

Frequently asked questions

How much free cash flow does LITS generate?

LITS produced $-20.84M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is LITS's balance sheet healthy?

LITS holds $18.01M in cash and equivalents against — in long-term debt, on $16.93M of shareholder equity. That debt is best read against the cash flow the business throws off each year.